Related references
Note: Only part of the references are listed.Asymmetric Dimethylarginine at Sea Level Is a Predictive Marker of Hypoxic Pulmonary Arterial Hypertension at High Altitude
Patricia Siques et al.
FRONTIERS IN PHYSIOLOGY (2019)
The Effect of Oxygen Enrichment on Cardiorespiratory and Neuropsychological Responses in Workers With Chronic Intermittent Exposure to High Altitude (ALMA, 5,050 m)
Fernando A. Moraga et al.
FRONTIERS IN PHYSIOLOGY (2018)
Plasmatic Concentrations of ADMA and Homocystein in Llama (Lama glama) and Regulation of Arginase Type II: An Animal Resistent to the Development of Pulmonary Hypertension Induced by Hypoxia
Vasthi Lopez et al.
FRONTIERS IN PHYSIOLOGY (2018)
Long-Term Intermittent Exposure to High Altitude Elevates Asymmetric Dimethylarginine in First Exposed Young Adults
Nicole Lueneburg et al.
HIGH ALTITUDE MEDICINE & BIOLOGY (2017)
An assessment of correlation between serum asymmetric dimethylarginine and glycated haemoglobin in patients with type 2 diabetes mellitus
Asija Začiragić et al.
Bosnian Journal of Basic Medical Sciences (2017)
Dimethylarginine Dimethylaminohydrolase 2 (DDAH 2) Gene Polymorphism, Asymmetric Dimethylarginine (ADMA) Concentrations, and Risk of Coronary Artery Disease: A Case-Control Study
Chao Xuan et al.
SCIENTIFIC REPORTS (2016)
Prevalence of hypertension at high altitude: cross-sectional survey in Ladakh, Northern India 2007-2011
Tsering Norboo et al.
BMJ OPEN (2015)
Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: a randomized clinical trial
Gianfranco Parati et al.
EUROPEAN HEART JOURNAL (2014)
A case of homocystinuria due to CBS gene mutations revealed by cerebral venous thrombosis
Mariana Sarov et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia
Carlo Cervellati et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Notable epigenetic role of hyperhomocysteinemia in atherogenesis
Shuyu Zhou et al.
LIPIDS IN HEALTH AND DISEASE (2014)
Endothelial dysfunction in patients with primary hypertension and hyperhomocysteinemia
Aleksandra Baszczuk et al.
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ (2014)
Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease
Joyce B. J. van Meurs et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2013)
Nitric Oxide Deficiency and Endothelial Dysfunction in Pulmonary Arterial Hypertension
James R. Klinger et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Association of homocysteinaemia with hyperglycaemia, dyslipidaemia, hypertension and obesity
Dudu Sengwayo et al.
CARDIOVASCULAR JOURNAL OF AFRICA (2013)
Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?
John Pernow et al.
CARDIOVASCULAR RESEARCH (2013)
Assessment of L-arginine asymmetric 1 dimethyl (ADMA) in early-onset and late-onset (severe) preeclampsia
Patricia Nessralla Alpoim et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2013)
The association of Cystathionine β Synthase (CBS) T833C polymorphism and the risk of stroke: A meta-analysis
Rui Ding et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Polymorphisms in MTHFR, MS and CBS Genes and Homocysteine Levels in a Pakistani Population
Mohsin Yakub et al.
PLOS ONE (2012)
ASYMMETRIC DIMETHYLARGININE (ADMA) AND ENDOTHELIAL DYSFUNCTION: IMPLICATIONS FOR ATHEROGENESIS
Mauricio Batista Paes Landim et al.
CLINICS (2009)
Upregulation of Arginase Expression and Activity in Hypertensive Rats Exposed to Chronic Intermittent Hypobaric Hypoxia
Vasthi Lopez et al.
HIGH ALTITUDE MEDICINE & BIOLOGY (2009)
Sialic acid, homocysteine and CRP: Potential markers for dementia
Gershwin Davis et al.
NEUROSCIENCE LETTERS (2009)
Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-An update on patient populations with a wide range of cardiovascular risk
Rainer H. Boeger et al.
PHARMACOLOGICAL RESEARCH (2009)
Alterations in lung arginine metabolism in lambs with pulmonary hypertension associated with increased pulmonary blood flow
Shruti Sharma et al.
VASCULAR PHARMACOLOGY (2009)
Pollymorphisms in the CBS Gene and Homocysteine, Folate and Vitamin B12 Levels: Association With Polymorphisms in the MTHFR and MTRR Genes in Brazilian Children
Ana C. M. Alessio et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2008)
Carbon monoxide: a novel pulmonary artery vasodilator in neonatal llamas of the Andean altiplano
Emilio A. Herrera et al.
CARDIOVASCULAR RESEARCH (2008)
Endothelial function and hypertension
Ulf Landmesser et al.
CURRENT OPINION IN CARDIOLOGY (2007)
Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats
Akihito Sasaki et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Up-regulation of arginase activity contributes to attenuated reflex cutaneous vasodilatation in hypertensive humans
Lacy A. Holowatz et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
Asymmetric dimethyl-arginine and coronary artery calcification in young adults entering middle age: the CARDIA study
Carlos Iribarren et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2007)
Asymmetric dimethylarginine is an independent risk factor for coronary heart disease:: Results from the multicenter coronary artery risk determination investigating the influence of ADMA concentration (CARDIAC) study
Friedrich Schulze et al.
AMERICAN HEART JOURNAL (2006)
Amino acids, arginase and nitric oxide in vascular health
NN Huynh et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2006)
Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension
S Pullamsetti et al.
FASEB JOURNAL (2005)
Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension
FK Johnson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2005)
Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathways
T Suhara et al.
HYPERTENSION (2004)
Asymmetric dimethylarginine, and endogenous inhibitor of nitric oxide synthase, explains the L-arginine paradox and acts as a novel cardiovascular risk factor
RH Böger
JOURNAL OF NUTRITION (2004)
Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia
FI Arrigoni et al.
CIRCULATION (2003)
The DDAH/ADMA/NOS pathway
CTL Tran et al.
ATHEROSCLEROSIS SUPPLEMENTS (2003)
Plasma levels of asymmetrical dimethyl-L-arginine in patients with congenital heart disease and pulmonary hypertension
M Gorenflo et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2001)